Article
Personalized mRNA vaccine boosts melanoma immunotherapy
Rating:
0.0
Views:
32
Likes:
1
Library:
1
In patients with resected, high-risk melanoma, the addition of a personalized mRNA-based neoantigen therapy to adjuvant pembrolizumab was more effective than pembrolizumab alone.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value